Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Introduction The guidelines' recommendations for anticoagulation in cancer patients with catheter-related thrombosis are unclear. The aim of this systematic review was to assess anticoagulation management in cancer patients with catheter-related thrombosis (CRT) based on previously published studies.

Thrombosis 69

Thrombosis Cancer Outcomes 69

Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

Long COVID-19 was associated with a higher risk of thromboembolic disorders [HR 3.12 (1.60, 6.08)], coronary heart disease [HR 1.61 (1.13, 2.31)], stroke [HR 1.71 (1.07,2.72)], arrhythmia [HR 1.60 (1.13, 2.26)], cardiomyopathy [HR 1.71 (1.12, 2.61)], myocarditis [HR 6.11 (4.17,8.94)], hypertension [HR 1.70 (1.56, 1.85)], heart failure [HR 1.72 (1.15,2.59)] (..)

COVID-19 95

COVID-19 Cardiogenic Shock Cardiomyopathy Outcomes 95

Medical Xpress - Cardiology

FEBRUARY 23, 2024

A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis—the formation of blood clots—researchers report February 23 in the journal Cell Metabolism.

COVID-19 126

COVID-19 Blood Clot Research Thrombosis 126

CardiacWire

NOVEMBER 13, 2024

Patients who didn’t have their IVC filters removed had significant rates of filter-related complications (1.4%), caval thrombosis (2.2%), DVT hospital visits (9.2%), and new deep vein thrombosis (21.2%).

Blood Clot 59

Blood Clot Thrombosis Embolism Medicare 59

Medical Xpress - Cardiology

FEBRUARY 25, 2025

This innovation promises to transform treatment for life-threatening vascular conditions like thrombosis. Researchers at the TechMed Center of the University of Twente and Radboud University Medical Center have removed blood clots with wireless magnetic robots.

Blood Clot 110

Blood Clot Thrombosis Innovation Research 110

Cardiovascular Diabetology

FEBRUARY 19, 2024

Early since the onset of the COVID-19 pandemic, the medical and scientific community were aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation, and hypofibrinolysis were i.

COVID-19 111

COVID-19 Thrombosis Diabetes 111

American Heart News - Stroke News

JANUARY 29, 2024

DALLAS, January 29, 2024 — A new scientific statement from the American Heart Association emphasizes the need to increase patients’ and physicians’ awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate.

Risk Factors 133

Risk Factors Thrombosis Stroke Strokes 133

Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

BackgroundArterial thrombosis is an uncommon complication in cancer patients, often overshadowed by venous thromboembolic events.

Thrombosis 52

Thrombosis Cancer Best Practices Aortic 52

Journal of Cardiothoracic Surgery

JUNE 25, 2024

Intra-cardiac thrombosis is a potentially devastating complication of extracorporeal membrane oxygenation (ECMO) mechanical circulatory support. We present here a patient who suffered complete thrombosis of a.

Thrombosis 52

Thrombosis Bicuspid/Mitral Outcomes 52

ECG Cases

APRIL 11, 2023

How do the presentations of cerebral venous thrombosis (CVT) and idiopathic intracranial hypertension (IIH) compare and contrast? The post Ep181 Cerebral Venous Thrombosis, Idiopathic Intracranial Hypertension, Giant Cell Arteritis and Peripartum Headaches appeared first on Emergency Medicine Cases. and many more.

Thrombosis 52

Thrombosis Hypertension 52

Science Daily - Heart Disease

OCTOBER 16, 2024

New research has shown that over the long-term, standing more compared with sitting does not improve cardiovascular health (coronary heart disease, stroke and heart failure), and could increase the risk of circulatory issues related to standing, such as varicose veins and deep vein thrombosis.

Research 117

Research Cardiovascular Disease Thrombosis Heart Failure 117

Medical Xpress - Cardiology

JANUARY 10, 2025

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by University of Pittsburgh School of Medicine and UPMC surgeon-scientists and published today in the Journal of Thrombosis and Haemostasis.

Blood Clot 116

Blood Clot Heart Attack Heart attacks Thrombosis 116

Frontiers in Cardiovascular Medicine

JULY 5, 2024

Left-sided bioprosthesis valve thrombosis (LSBVT) is a challenging complication necessitating invasive interventions. In this study, we introduce a novel, minimally invasive approach.

Thrombosis 52

Thrombosis Embolism 52

American College of Cardiology

JANUARY 14, 2025

The optimal management of isolated, distal deep vein thrombosis (DVT) remains unclear. Data from recent studies suggest that certain patients may benefit from anticoagulation.

Thrombosis 45

Thrombosis Outcomes Article 45

Frontiers in Cardiovascular Medicine

FEBRUARY 21, 2024

Acute extensive portal venous system thrombosis (PVST) can cause lethal complications. Herein, we have for the first time reported the use of anticoagulation combined with systemic thrombolysis by tenecteplase in a male patient with a diagnosis of acute extensive PVST but without liver cirrhosis.

Thrombosis 59

Thrombosis Thrombolysis 59

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Background Deep vein thrombosis (DVT) is associated with aberrant gene expression that is a common peripheral vascular disease. Methods In order to explore the relationship between microRNAs (miRNAs) and FOXP3, mRNA and microRNA microarray analysis were performed.

Thrombosis 59

Thrombosis Ultrasound 59

Journal of Cardiothoracic Surgery

JANUARY 19, 2025

To assess the effectiveness and safety profiles of rivaroxaban compared to low molecular weight heparin (LMWH) in managing lower extremity deep vein thrombosis (DVT) subsequent to thoracoscopic lung cancer sur.

Thrombosis 52

Thrombosis Cancer Research 52

American College of Cardiology

JANUARY 6, 2025

Subclinical leaflet thrombosis (SLT) has raised concerns about the long-term durability and outcomes of transcatheter aortic valve replacement (TAVR). Clinical valve thrombosis (CVT) is a rare complication after TAVR with an incidence of 0.62.8%

Thrombosis 40

Thrombosis TAVR Aortic valve Aortic 40

Frontiers in Cardiovascular Medicine

JULY 1, 2024

Notably, acute massive pulmonary embolism (PE) with bilateral atrial thrombosis is an exceptional occurrence in CAPS. Acute massive PE combined with bilateral atrial thrombosis has an even higher mortality rate. Acute pulmonary embolism (PE) is a common cardiovascular disease that progresses rapidly and has a high mortality rate.

Thrombosis 52

Thrombosis Embolism Pulmonary Laboratory 52

Stroke Journal

FEBRUARY 1, 2024

Introduction:Deep medullary vein(DMV) thrombosis is a rare cause of neurological damage noted in both term and preterm infants. Although their incidence in children is not know, DMV thrombosis can occur isolated or in association with cerebral sinovenous thrombosis (CSVT). In none of these cases treatment options were described.

Thrombosis 40

Thrombosis Hemorrhage Stroke Strokes 40

Dr. Anish Koka

DECEMBER 13, 2023

of patients in the WATCHMAN arm had evidence of a definite or probably Device Related Thrombosis (DRT). Reflecting contemporary practice, most patients at 45 days after implant were either on single antiplatelet or dual antiplatelet therapy. At one year, 10% of patients in both arms were dead, and 9.9%

Thrombosis 59

Thrombosis Atrial Fibrillation Stroke Strokes 59

DAIC

SEPTEMBER 10, 2024

Angiolillo, MD, PhD, FACC, FESC, FSCAI, Professor of Medicine, Chief, Division of Cardiology, Director, Thrombosis Research Center, University of Florida, College of Medicine-Jacksonville. The Prolocor pFCG test will be an important asset as we tailor antiplatelet therapies to balance thrombotic and bleeding risk" said Dominick J.

Thrombosis 52

Thrombosis Coronary Artery Disease Stents Stent 52

Med Page Today

OCTOBER 15, 2024

Arteriosclerosis, Thrombosis, and Vascular Biology. (MedPage Today) -- Severe COVID-19 infection was associated with major cardiac events as much as -- and in some cases more than -- having a history of heart disease, U.K. Biobank data showed.

COVID-19 96

COVID-19 Thrombosis Heart Disease 96

Journal of the American Heart Association

DECEMBER 24, 2024

Improved recognition of biomarker research and a greater emphasis on mechanistic evidence can better equip clinicians to deal with the uncertainty that defines the practice of thrombosis medicine.

Biomarkers 45

Biomarkers Thrombosis Research Innovation 45

Medical Xpress - Cardiology

AUGUST 19, 2024

Therefore, preventing and treating thrombosis is crucial to avoid severe complications. An unhealthy lifestyle, diseases or injuries, genetic predisposition, and increased coagulation tendency can promote the formation of thrombi in blood vessels.

Genetic predisposition 95

Genetic predisposition Thrombosis 95

Frontiers in Cardiovascular Medicine

JANUARY 30, 2025

However, innovation in MHV design faces several challenges: strict performance and biocompatibility requirements, limited understanding of the mechanisms underlying MHV thrombosis, and a lack of effective testing methodologies to assess how design variations impact both hemodynamic performance and thrombogenicity of MHVs.

Heart Valves 52

Heart Valves Aortic Aortic valve Blood Clot 52

Circulation

NOVEMBER 11, 2024

Introduction:Subclinical leaflet thrombosis is an increasingly recognized complication in patients undergoing transcatheter aortic valve replacement (TAVR). The optimized TAV design could reduce the risk of subclinical leaflet thrombosis in patients undergoing TAVR.

Aortic valve 40

Aortic valve Thrombosis Aortic TAVR 40

Frontiers in Cardiovascular Medicine

DECEMBER 17, 2023

Background D-Dimer testing is a diagnostic tool for exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE). This study evaluated the diagnostic performance of the Tina-quant® D-Dimer Gen.2

Thrombosis 64

Thrombosis Embolism Pulmonary Laboratory 64

Cardiology Update

FEBRUARY 11, 2024

Bioprosthetic valve dysfunction (BVD) was categorized into structural valve deterioration (SVD), non-structural valve dysfunction (NSVD), clinical valve thrombosis, or endocarditis. No cases of clinical valve thrombosis were reported. Severe SVD was defined by specific criteria.

Aortic valve 124

Aortic valve Aortic Outcomes Thrombosis 124

American College of Cardiology

MARCH 12, 2025

According to a new study published in JACC, there is a strong dose-response relationship between cigarette smoking and three different domains of subclinical cardiovascular markers: inflammation, thrombosis and subclinical atherosclerosis.

Thrombosis 75

Thrombosis Atherosclerosis Article 75

Open Heart

MARCH 3, 2025

vs 35.2%, p<0.001), the rate of acute stent thrombosis (ST) was significantly lower than in the BP-DES group (HR 0.240, 95% CI 0.075 to 0.766; p=0.016). Despite the DP-DES group exhibiting significantly higher rates of risk factors, such as arterial hypertension (63.1% vs 50.2%, p=0.031) and a higher rate of post-dilatation (42.2%

Stents 52

Stents Stent Myocardial Infarction Angioplasty 52

Stroke Journal

JANUARY 30, 2025

Background:Newer Oral Anticoagulants (NOACs) offer potential advantages for patients with cerebral venous sinus thrombosis (CVST). NOACs treatment may reduced mortality at six months and good functional outcome compared with warfarin.Keywords:new oral anticoagulants; cerebral venous sinus thrombosis; warfarin; propensity score matching

Thrombosis 40

Thrombosis Hospital Outcomes Stroke 40

Circulation

SEPTEMBER 15, 2024

Circulation, Volume 150, Issue 12 , Page 905-907, September 17, 2024.

Thrombosis 45

Thrombosis Circulation 45

American College of Cardiology

JANUARY 9, 2024

Active cancer is a strong risk factor for venous thromboembolism (VTE) events and recurrent events following discontinuation of anticoagulation therapy, and cancer patients are also at a heightened risk for bleeding complications related to anticoagulation treatment.

Cancer 60

Cancer Thrombosis Risk Factors Article 60

The New England Journal of Medicine

JANUARY 22, 2025

This editorial describes the science behind a clinical trial reported by Ruff et al. in which a monoclonal antibody targeting factors XI and XIa was evaluated for its effects on bleeding events in patients with atrial fibrillation.

Thrombosis 58

Thrombosis Atrial Fibrillation 58

HCPLive

JANUARY 2, 2025

Bendapudi gave an overview of 2 studies presented at ASH 2024 from his Harvard lab.

Thrombosis 59

Thrombosis 59

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCerebral venous sinus thrombosis (CVST) is a rare form of stroke that usually affects young females especially during pregnancy and the postpartum period. The symptoms of cerebral venous sinus thrombosis can vary depending on the location and extent of the clot.

Thrombosis 40

Thrombosis Outcomes Cancer Risk Factors 40